Format

Send to

Choose Destination
Antimicrob Agents Chemother. 2017 Jul 25;61(8). pii: e00448-17. doi: 10.1128/AAC.00448-17. Print 2017 Aug.

The Fluorocycline TP-271 Is Efficacious in Models of Aerosolized Francisella tularensis SCHU S4 Infection in BALB/c Mice and Cynomolgus Macaques.

Author information

1
Tetraphase Pharmaceuticals, Inc., Watertown, Massachusetts, USA tgrossman@yahoo.com.
2
Battelle, Columbus, Ohio, USA.
3
SNC Partners, LLC, Newark, Delaware, USA.
4
CUBRC, Inc., Buffalo, New York, USA.
5
United States Army Medical Research Institute of Infectious Diseases, Frederick, Maryland, USA.
6
Pathways Toxicology Consulting, LLC, Lahaska, Pennsylvania, USA.
7
IIT Research Institute, Chicago, Illinois, USA.
8
University of Houston College of Pharmacy, Houston, Texas, USA.
9
Tetraphase Pharmaceuticals, Inc., Watertown, Massachusetts, USA.

Abstract

TP-271 is a novel, fully synthetic fluorocycline in development for complicated bacterial respiratory infections. TP-271 was active in vitro against a panel of 29 Francisella tularensis isolates, showing MICs against 50% and 90% of isolates of 0.25 and 0.5 μg/ml, respectively. In a mouse model of inhalational tularemia, animals were exposed by aerosol to 91 to 283 50% lethal doses (LD50)/mouse of F. tularensis SCHU S4. Following 21 days of once-daily intraperitoneal dosing with TP-271 at 3, 6, 12, and 18 mg/kg of body weight/day, initiating at 24 h postchallenge, survival was 80%, 100%, 100%, and 100%, respectively. When treatment was initiated at 72 h postchallenge, survival was 89%, 100%, 100%, and 100% in the 3-, 6-, 12-, and 18-mg/kg/day TP-271 groups, respectively. No mice treated with the vehicle control survived. Surviving mice treated with TP-271 showed little to no relapse during 14 days posttreatment. In a nonhuman primate model of inhalational tularemia, cynomolgus macaques received an average aerosol exposure of 1,144 CFU of F. tularensis SCHU S4. Once-daily intravenous infusion with 1 or 3 mg/kg TP-271, or vehicle control, for 21 days was initiated within 6 h of confirmed fever. All animals treated with TP-271 survived to the end of the study, with no relapse during 14 days after the last treatment, whereas no vehicle control-treated animals survived. The protection and low relapse afforded by TP-271 treatment in these studies support continued investigation of TP-271 for use in the event of aerosolized exposure to F. tularensis.

KEYWORDS:

Francisella tularensis; TP-271; fluorocycline; tularemia

PMID:
28559261
PMCID:
PMC5527625
DOI:
10.1128/AAC.00448-17
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for HighWire Icon for PubMed Central
Loading ...
Support Center